About the Book
PART I: Molecular Characterization
1. Analysis of Chromosomal Alterations in Urothelial Carcinoma
Donatella Conconi and Angela Bentivegna
2. Analysis of Point Mutations in Clinical Samples of Urothelial Carcinoma
Mustafa Alamyar and Ellen C. Zwarthoff
3. A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer
Stella Tommasi and Ahmad Besaratinia
4. Immunohistochemical Analysis of UC Tissues for Proliferation and Differentiation Markers
Michael Rose and Nadine Therese Gaisa
5. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel
Gottfrid Sjödahl
PART II: Urothelial Carcinogenesis
6. Defining the Pathways of Urogenital Schistosomiasis-associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models
Evaristus C. Mbanefo and Michael H. Hsieh
7. Algorithm for the Automated Evaluation of NAT2 Genotypes
Georg Michael, Ricarda Thier, Meinolf Blaszkewicz, Silvia Selinski, and Klaus Golka
8. Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma
Ananda Ayyappan Jaguva Vasudevan, Wolfgang Göring, Dieter Häussinger, and Carsten Münk
9. Oxidative Stress in Urothelial Carcinogenesis: Measurements of Protein Carbonylation and Intracellular Production of Reactive Oxygen Species
Patcharawalai Whongsiri, Suchittra Phoyen, and Chanchai Boonla
PART III: Cellular and ANIMAL MODELS
10. Urothelial Carcinoma Stem Cells - current Concepts, Controversies, and Methods
Jiri Hatina, Hamendra Singh Parmar, Michaela Kripnerova, Anastasia Hepburn, and Rakesh Heer
11.
12. Spheroid Cultures of Primary Urothelial Cancer Cells: Cancer Tissue-originated Spheroid (CTOS) Method
Takahiro Yoshida, Hiroaki Okuyama, Hiroko Endo, and Masahiro lnoue
13. The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model
Paula Alexandra Oliveira, Cármen Vasconcelos-Nóbrega, Rui Manuel Gil da Costa, and Regina Arantes-Rodrigues
14. Patient-derived Bladder Cancer Xenografts
Carina Bernardo and Lúcio Lara Santos
15. Wolfgang Jäger, Igor Moskalev, Peter Raven, Akihiro Goriki, Samir Bidnur, and Peter C. Black
PART IV: Biomarkers
16. Quantification of microRNAs in Urine-derived Specimens
Susanne Fuessel, Andrea Lohse-Fischer, Dana Vu Van, Karsten Salomo, Kati Erdmann, and Manfred P. Wirth
17. Quantitative RNA Analysis from Urine using Real Time PCR
Lourdes Mengual and Mireia Olivan
18. DNA Methylation Analysis from Body Fluids
Dimo Dietrich
19. Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma
Tibor Szarvas, Péter Nyirády, Takashi Kobayashi, Osamu Ogawa, Hideki Furuya, and Charles J. Rosser
20. Isolation and Characterization of CTCs from Patients with Cancer of a Urothelial Origin
Vladimir Bobek and Katarina Kolostova
PART V: Therapy Development
21. Epigenetic Treatment Options in Urothelial Carcinoma
Guenter Niegisch, Maria Pinkerneil, and Michèle Hoffmann
22. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum
Leandro S. D'Abronzo, Chong-Xian Pan, and Paramita M. Ghosh
23. Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer
Anuja Sathe and Roman Nawroth
24. Visualization and Quantitative Measurement of Frug-induced Platinum Sdducts in the Nuclear DNA of Individual Cells by an Immuno-cytological Sssay
Margarita Melnikova and Jürgen Thomale
